TRANSGLIOMA
New treatments for glioblastoma through a cross-border translational research platform
01/2016 - 1b
Basic information
-
Brief description of the consultancy firmTRANSGLIOMA faces the challenges identified by the EU2020 plan and the Italy-Slovenia Program. It is an implementation of the Interreg GLIOMA project, which discovered new cancer stem cell markers which will be used in a clinical environment for early diagnosis, response to treatment and as a therapeutic target. The innovative approach will allow single patients to receive a personalised treatment, contributing to an improvement in the quality of life of patients with brain tumours.
- Planned start of the project 01.09.2017 Expected end of project 29.02.2020
- Duration 29 (Month(s) )
Budget
- Program Total Budget 1302252 Project EU-Funding 1106915 Percent: 85
Partners
DOCUMENTS
-
there are currently no documents available for this record